current clinical practice would recommend intravenous nitroglycerin as initial adjunctive therapy for patients receiving intravenous thrombolytic therapy and/or acute percutaneous transluminal angioplasty within 4-6 h of the onset of symptoms of acute myocardial infarction , with the goal of optimizing collateral flow until reperfusion can be accomplished .
C0017887
nitroglycerin
C0027051
myocardial